This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.

This article is published in the Journal of Medical Ethics.

Excerpt (first paragraph, excluding footnotes)

The border between Thailand and Burma (Myanmar) is at the forefront of the global battle against malaria, and is an important site for research. The primary reason for this is the fact that it is on the front line in the battle against the development and spread of resistance to antimalarial drugs. That is, it is one of the primary sites of the arms race between the development of new drugs for the treatment of malaria and the evolution of antimalarial resistance in parasites. The antimalarial resistance developing here is likely to spread elsewhere. So, much is at stake. Globally, up to a million children each year die from malaria and more than half a billion people are affected.

The full article is available in PDF format in the upper right hand side of this page.

You can also read the article online at:

This article is freely available through open access.

The author has begun a discussion of this article in a blog: